Evidence map›Paper›PMID 26901150›Full record

ArticleNature immunology2016

The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity.

Alicia Gonzalez-Martin, Brian D Adams, Maoyi Lai, Jovan Shepherd, Maria Salvador-Bernaldez, Jesus M Salvador, Jun Lu, David Nemazee, Changchun Xiao

Abstract read
In one paragraph

Article in Nature immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 149 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Overview of the Different Classes of Small RNAs During B-Cell Development.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Alicia Gonzalez-MartinDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Brian D AdamsDepartment of Genetics, Yale Stem Cell Center, Yale Cancer Center, and Yale Center for RNA Science and Medicine, Yale University, New Haven, Connecticut, USA.ORCID http://orcid.org/0000-0001-8372-2970
Maoyi LaiDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Jovan ShepherdDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Maria Salvador-BernaldezDepartment of Immunology and Oncology, National Biotechnology Center, Madrid, Spain.
Jesus M SalvadorDepartment of Immunology and Oncology, National Biotechnology Center, Madrid, Spain.
Jun LuDepartment of Genetics, Yale Stem Cell Center, Yale Cancer Center, and Yale Center for RNA Science and Medicine, Yale University, New Haven, Connecticut, USA.
David NemazeeDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Changchun XiaoDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.ORCID http://orcid.org/0000-0001-8754-3208
Scripps Research Institute · USCentro Nacional de Biotecnología · ESYale Cancer Center · US

Funding

New players in immune function: identification through RNAi and micro-RNA screensRC4AI092763 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL, RAO, ANJANA · 2010 to 2010
$12.6M
Immune Tolerance in Non-Clonal Immune SystemsR01AI059714 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 2004 to 2013
$3.9M
Immune Tolerance in Non-Clonal Immune SystemsR37AI059714 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 2014 to 2020
$3.5M
The role of microRNAs in leukemic initiation and maintenanceR01CA149109 · NCI · YALE UNIVERSITY · PI LU, JUN · 2011 to 2015
$1.7M
Functional Analysis of MicroRNAs in Lymphocyte Development and Immune ToleranceR01AI089854 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI XIAO, CHANGCHUN · 2011 to 2014
$1.2M
NCI NIH HHS R01 CA149109NIAID NIH HHS R01 AI059714NIAID NIH HHS R01 AI089854NIAID NIH HHS R01 AI59714NIAID NIH HHS R37 AI059714NIAID NIH HHS RC4 AI092763
6 · The paper itself

Abstract

Autoreactive B cells have critical roles in a large diversity of autoimmune diseases, but the molecular pathways that control these cells remain poorly understood. We performed an in vivo functional screen of a lymphocyte-expressed microRNA library and identified miR-148a as a potent regulator of B cell tolerance. Elevated miR-148a expression impaired B cell tolerance by promoting the survival of immature B cells after engagement of the B cell antigen receptor by suppressing the expression of the autoimmune suppressor Gadd45α, the tumor suppressor PTEN and the pro-apoptotic protein Bim. Furthermore, increased expression of miR-148a, which occurs frequently in patients with lupus and lupus-prone mice, facilitated the development of lethal autoimmune disease in a mouse model of lupus. Our studies demonstrate a function for miR-148a as a regulator of B cell tolerance and autoimmunity.

Indexed as

AnimalsApoptosisApoptosis Regulatory ProteinsAutoimmunityBcl-2-Like Protein 11B-LymphocytesBone Marrow TransplantationCell Cycle ProteinsCell ProliferationDisease Models, AnimalGADD45 ProteinsHEK293 CellsHumansImmune ToleranceImmunoblottingLupus Erythematosus, SystemicApoptosis Regulatory ProteinsBCL2L11 protein, humanBcl2l11 protein, mouseBcl-2-Like Protein 11Cell Cycle ProteinsGadd45a protein, mouseGADD45 ProteinsMembrane ProteinsMicroRNAsMirn148 microRNA, mouseNuclear ProteinsProto-Oncogene ProteinsPTEN PhosphohydrolasePten protein, mouse

Identifiers

PMID26901150
PMCPMC4803625
OpenAlexW2287188530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.